Cognivia

Cognivia is a leading brand in the field of clinical trials, offering innovative solutions to manage key sources of data variability. With the help of predictive algorithms and patient psychology tools, Cognivia aims to reduce clinical trial data variability by up to 30%. Their groundbreaking approach combines a thorough evaluation of patient characteristics and traits with machine learning to address placebo response, improve patient adherence, and reduce dropouts.

Cognivia offers two key products: PlacebellⓇ, which predicts each patient's placebo responsiveness, resulting in increased study power and reduced risks of trial failure, and Compl-AI©™, a unique tool that predicts the risk of non-adherence and dropouts to optimize patient engagement strategy. In addition to their technology solutions, Cognivia also provides expert post-hoc analysis services to characterize site differences and detect sources of clinical site variability. Trusted by innovative sponsors worldwide, Cognivia has been recognized for its industry expertise and commitment to driving the next era of drug development.

Contact Cognivia today and experience their comprehensive solutions firsthand